nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00143	0.0018	CcSEcCtD
Betahistine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00143	0.00179	CcSEcCtD
Betahistine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00142	0.00178	CcSEcCtD
Betahistine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00141	0.00178	CcSEcCtD
Betahistine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.0014	0.00176	CcSEcCtD
Betahistine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.0014	0.00176	CcSEcCtD
Betahistine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.0014	0.00176	CcSEcCtD
Betahistine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00139	0.00175	CcSEcCtD
Betahistine—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00139	0.00175	CcSEcCtD
Betahistine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00139	0.00174	CcSEcCtD
Betahistine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00137	0.00173	CcSEcCtD
Betahistine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00137	0.00173	CcSEcCtD
Betahistine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00136	0.00171	CcSEcCtD
Betahistine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00136	0.00171	CcSEcCtD
Betahistine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00136	0.00171	CcSEcCtD
Betahistine—Asthenia—Glipizide—type 2 diabetes mellitus	0.00136	0.00171	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00135	0.0017	CcSEcCtD
Betahistine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00135	0.0017	CcSEcCtD
Betahistine—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.00135	0.0017	CcSEcCtD
Betahistine—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00135	0.00169	CcSEcCtD
Betahistine—Angioedema—Valsartan—type 2 diabetes mellitus	0.00134	0.00169	CcSEcCtD
Betahistine—Pruritus—Glipizide—type 2 diabetes mellitus	0.00134	0.00168	CcSEcCtD
Betahistine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00133	0.00168	CcSEcCtD
Betahistine—Angioedema—Orlistat—type 2 diabetes mellitus	0.00133	0.00167	CcSEcCtD
Betahistine—Flatulence—Metformin—type 2 diabetes mellitus	0.00132	0.00166	CcSEcCtD
Betahistine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00132	0.00166	CcSEcCtD
Betahistine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00131	0.00165	CcSEcCtD
Betahistine—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00131	0.00165	CcSEcCtD
Betahistine—Malaise—Orlistat—type 2 diabetes mellitus	0.00131	0.00165	CcSEcCtD
Betahistine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.0013	0.00163	CcSEcCtD
Betahistine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.0013	0.00163	CcSEcCtD
Betahistine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.0013	0.00163	CcSEcCtD
Betahistine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00129	0.00163	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.00129	0.00163	CcSEcCtD
Betahistine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00129	0.00163	CcSEcCtD
Betahistine—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.00129	0.00162	CcSEcCtD
Betahistine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00128	0.00161	CcSEcCtD
Betahistine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00128	0.00161	CcSEcCtD
Betahistine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00128	0.00161	CcSEcCtD
Betahistine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00127	0.0016	CcSEcCtD
Betahistine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00127	0.0016	CcSEcCtD
Betahistine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00126	0.00159	CcSEcCtD
Betahistine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00126	0.00159	CcSEcCtD
Betahistine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00126	0.00159	CcSEcCtD
Betahistine—Convulsion—Orlistat—type 2 diabetes mellitus	0.00126	0.00158	CcSEcCtD
Betahistine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00126	0.00158	CcSEcCtD
Betahistine—Dizziness—Glipizide—type 2 diabetes mellitus	0.00125	0.00157	CcSEcCtD
Betahistine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00125	0.00157	CcSEcCtD
Betahistine—Flatulence—Irbesartan—type 2 diabetes mellitus	0.00124	0.00157	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00124	0.00156	CcSEcCtD
Betahistine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00124	0.00156	CcSEcCtD
Betahistine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00124	0.00156	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00123	0.00155	CcSEcCtD
Betahistine—Discomfort—Orlistat—type 2 diabetes mellitus	0.00122	0.00154	CcSEcCtD
Betahistine—Malaise—Metformin—type 2 diabetes mellitus	0.00121	0.00152	CcSEcCtD
Betahistine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00121	0.00152	CcSEcCtD
Betahistine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.0012	0.00151	CcSEcCtD
Betahistine—Vomiting—Glipizide—type 2 diabetes mellitus	0.0012	0.00151	CcSEcCtD
Betahistine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.0012	0.00151	CcSEcCtD
Betahistine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.0012	0.00151	CcSEcCtD
Betahistine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.0012	0.00151	CcSEcCtD
Betahistine—Rash—Glipizide—type 2 diabetes mellitus	0.00119	0.0015	CcSEcCtD
Betahistine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00119	0.0015	CcSEcCtD
Betahistine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00119	0.00149	CcSEcCtD
Betahistine—Headache—Glipizide—type 2 diabetes mellitus	0.00118	0.00149	CcSEcCtD
Betahistine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00118	0.00148	CcSEcCtD
Betahistine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00117	0.00147	CcSEcCtD
Betahistine—Flatulence—Losartan—type 2 diabetes mellitus	0.00117	0.00147	CcSEcCtD
Betahistine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00117	0.00147	CcSEcCtD
Betahistine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00117	0.00147	CcSEcCtD
Betahistine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00116	0.00146	CcSEcCtD
Betahistine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00116	0.00146	CcSEcCtD
Betahistine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00116	0.00146	CcSEcCtD
Betahistine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00116	0.00146	CcSEcCtD
Betahistine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00116	0.00145	CcSEcCtD
Betahistine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00115	0.00145	CcSEcCtD
Betahistine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00115	0.00145	CcSEcCtD
Betahistine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00115	0.00145	CcSEcCtD
Betahistine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00114	0.00144	CcSEcCtD
Betahistine—Malaise—Irbesartan—type 2 diabetes mellitus	0.00114	0.00143	CcSEcCtD
Betahistine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00113	0.00143	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00113	0.00142	CcSEcCtD
Betahistine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00113	0.00142	CcSEcCtD
Betahistine—Discomfort—Metformin—type 2 diabetes mellitus	0.00113	0.00142	CcSEcCtD
Betahistine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00113	0.00142	CcSEcCtD
Betahistine—Nausea—Glipizide—type 2 diabetes mellitus	0.00112	0.00141	CcSEcCtD
Betahistine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00112	0.00141	CcSEcCtD
Betahistine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00112	0.00141	CcSEcCtD
Betahistine—Rash—Glimepiride—type 2 diabetes mellitus	0.00111	0.0014	CcSEcCtD
Betahistine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00111	0.0014	CcSEcCtD
Betahistine—Rash—Sitagliptin—type 2 diabetes mellitus	0.00111	0.00139	CcSEcCtD
Betahistine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00111	0.00139	CcSEcCtD
Betahistine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.00111	0.00139	CcSEcCtD
Betahistine—Headache—Glimepiride—type 2 diabetes mellitus	0.0011	0.00139	CcSEcCtD
Betahistine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.0011	0.00139	CcSEcCtD
Betahistine—Headache—Sitagliptin—type 2 diabetes mellitus	0.0011	0.00139	CcSEcCtD
Betahistine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00109	0.00137	CcSEcCtD
Betahistine—Angioedema—Losartan—type 2 diabetes mellitus	0.00109	0.00137	CcSEcCtD
Betahistine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00108	0.00135	CcSEcCtD
Betahistine—Malaise—Losartan—type 2 diabetes mellitus	0.00107	0.00135	CcSEcCtD
Betahistine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00107	0.00135	CcSEcCtD
Betahistine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00107	0.00135	CcSEcCtD
Betahistine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00107	0.00135	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00107	0.00134	CcSEcCtD
Betahistine—Somnolence—Valsartan—type 2 diabetes mellitus	0.00107	0.00134	CcSEcCtD
Betahistine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00106	0.00134	CcSEcCtD
Betahistine—Skin disorder—Metformin—type 2 diabetes mellitus	0.00106	0.00134	CcSEcCtD
Betahistine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00106	0.00133	CcSEcCtD
Betahistine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00106	0.00133	CcSEcCtD
Betahistine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00105	0.00132	CcSEcCtD
Betahistine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00105	0.00132	CcSEcCtD
Betahistine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00104	0.00131	CcSEcCtD
Betahistine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00104	0.00131	CcSEcCtD
Betahistine—Asthenia—Glyburide—type 2 diabetes mellitus	0.00104	0.00131	CcSEcCtD
Betahistine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00104	0.00131	CcSEcCtD
Betahistine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00104	0.0013	CcSEcCtD
Betahistine—Fatigue—Valsartan—type 2 diabetes mellitus	0.00103	0.0013	CcSEcCtD
Betahistine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00103	0.0013	CcSEcCtD
Betahistine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00103	0.00129	CcSEcCtD
Betahistine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00102	0.00129	CcSEcCtD
Betahistine—Fatigue—Orlistat—type 2 diabetes mellitus	0.00102	0.00129	CcSEcCtD
Betahistine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00101	0.00127	CcSEcCtD
Betahistine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00101	0.00127	CcSEcCtD
Betahistine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00101	0.00127	CcSEcCtD
Betahistine—Rash—Bromocriptine—type 2 diabetes mellitus	0.001	0.00126	CcSEcCtD
Betahistine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.001	0.00126	CcSEcCtD
Betahistine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.001	0.00126	CcSEcCtD
Betahistine—Discomfort—Losartan—type 2 diabetes mellitus	0.001	0.00126	CcSEcCtD
Betahistine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000996	0.00125	CcSEcCtD
Betahistine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000995	0.00125	CcSEcCtD
Betahistine—Confusional state—Losartan—type 2 diabetes mellitus	0.000978	0.00123	CcSEcCtD
Betahistine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000977	0.00123	CcSEcCtD
Betahistine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000974	0.00123	CcSEcCtD
Betahistine—Somnolence—Metformin—type 2 diabetes mellitus	0.000971	0.00122	CcSEcCtD
Betahistine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00097	0.00122	CcSEcCtD
Betahistine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000962	0.00121	CcSEcCtD
Betahistine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000961	0.00121	CcSEcCtD
Betahistine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000953	0.0012	CcSEcCtD
Betahistine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000951	0.0012	CcSEcCtD
Betahistine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000947	0.00119	CcSEcCtD
Betahistine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000946	0.00119	CcSEcCtD
Betahistine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000945	0.00119	CcSEcCtD
Betahistine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000943	0.00119	CcSEcCtD
Betahistine—Fatigue—Metformin—type 2 diabetes mellitus	0.000942	0.00119	CcSEcCtD
Betahistine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000942	0.00118	CcSEcCtD
Betahistine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000937	0.00118	CcSEcCtD
Betahistine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000931	0.00117	CcSEcCtD
Betahistine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000924	0.00116	CcSEcCtD
Betahistine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000924	0.00116	CcSEcCtD
Betahistine—Malaise—Ramipril—type 2 diabetes mellitus	0.000919	0.00116	CcSEcCtD
Betahistine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000919	0.00116	CcSEcCtD
Betahistine—Rash—Glyburide—type 2 diabetes mellitus	0.000917	0.00115	CcSEcCtD
Betahistine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000916	0.00115	CcSEcCtD
Betahistine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000916	0.00115	CcSEcCtD
Betahistine—Headache—Glyburide—type 2 diabetes mellitus	0.000911	0.00115	CcSEcCtD
Betahistine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000907	0.00114	CcSEcCtD
Betahistine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.0009	0.00113	CcSEcCtD
Betahistine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000893	0.00112	CcSEcCtD
Betahistine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00089	0.00112	CcSEcCtD
Betahistine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000889	0.00112	CcSEcCtD
Betahistine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000884	0.00111	CcSEcCtD
Betahistine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000883	0.00111	CcSEcCtD
Betahistine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000873	0.0011	CcSEcCtD
Betahistine—Urticaria—Metformin—type 2 diabetes mellitus	0.000868	0.00109	CcSEcCtD
Betahistine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000865	0.00109	CcSEcCtD
Betahistine—Nausea—Glyburide—type 2 diabetes mellitus	0.000864	0.00109	CcSEcCtD
Betahistine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000863	0.00109	CcSEcCtD
Betahistine—Somnolence—Losartan—type 2 diabetes mellitus	0.000862	0.00109	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000862	0.00108	CcSEcCtD
Betahistine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000861	0.00108	CcSEcCtD
Betahistine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000857	0.00108	CcSEcCtD
Betahistine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000854	0.00107	CcSEcCtD
Betahistine—Asthenia—Orlistat—type 2 diabetes mellitus	0.00085	0.00107	CcSEcCtD
Betahistine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000849	0.00107	CcSEcCtD
Betahistine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000849	0.00107	CcSEcCtD
Betahistine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000839	0.00106	CcSEcCtD
Betahistine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000839	0.00106	CcSEcCtD
Betahistine—Fatigue—Losartan—type 2 diabetes mellitus	0.000836	0.00105	CcSEcCtD
Betahistine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000832	0.00105	CcSEcCtD
Betahistine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00083	0.00104	CcSEcCtD
Betahistine—Rash—Gliclazide—type 2 diabetes mellitus	0.000823	0.00104	CcSEcCtD
Betahistine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000822	0.00103	CcSEcCtD
Betahistine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000821	0.00103	CcSEcCtD
Betahistine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000819	0.00103	CcSEcCtD
Betahistine—Headache—Gliclazide—type 2 diabetes mellitus	0.000818	0.00103	CcSEcCtD
Betahistine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000816	0.00103	CcSEcCtD
Betahistine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000812	0.00102	CcSEcCtD
Betahistine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000811	0.00102	CcSEcCtD
Betahistine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000808	0.00102	CcSEcCtD
Betahistine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000799	0.00101	CcSEcCtD
Betahistine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000793	0.000998	CcSEcCtD
Betahistine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000784	0.000986	CcSEcCtD
Betahistine—Asthenia—Metformin—type 2 diabetes mellitus	0.000784	0.000986	CcSEcCtD
Betahistine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000775	0.000976	CcSEcCtD
Betahistine—Pruritus—Metformin—type 2 diabetes mellitus	0.000773	0.000973	CcSEcCtD
Betahistine—Urticaria—Losartan—type 2 diabetes mellitus	0.000771	0.00097	CcSEcCtD
Betahistine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000763	0.00096	CcSEcCtD
Betahistine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000759	0.000956	CcSEcCtD
Betahistine—Rash—Valsartan—type 2 diabetes mellitus	0.000756	0.000952	CcSEcCtD
Betahistine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000756	0.000951	CcSEcCtD
Betahistine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000754	0.000948	CcSEcCtD
Betahistine—Headache—Valsartan—type 2 diabetes mellitus	0.000751	0.000946	CcSEcCtD
Betahistine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000747	0.00094	CcSEcCtD
Betahistine—Rash—Orlistat—type 2 diabetes mellitus	0.000747	0.00094	CcSEcCtD
Betahistine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000747	0.00094	CcSEcCtD
Betahistine—Headache—Orlistat—type 2 diabetes mellitus	0.000742	0.000934	CcSEcCtD
Betahistine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000742	0.000933	CcSEcCtD
Betahistine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00074	0.000931	CcSEcCtD
Betahistine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000739	0.000931	CcSEcCtD
Betahistine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000732	0.000921	CcSEcCtD
Betahistine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000729	0.000918	CcSEcCtD
Betahistine—Dizziness—Metformin—type 2 diabetes mellitus	0.000722	0.000909	CcSEcCtD
Betahistine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000718	0.000904	CcSEcCtD
Betahistine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000717	0.000902	CcSEcCtD
Betahistine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000715	0.000899	CcSEcCtD
Betahistine—Nausea—Valsartan—type 2 diabetes mellitus	0.000712	0.000897	CcSEcCtD
Betahistine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000705	0.000888	CcSEcCtD
Betahistine—Nausea—Orlistat—type 2 diabetes mellitus	0.000704	0.000886	CcSEcCtD
Betahistine—Asthenia—Losartan—type 2 diabetes mellitus	0.000696	0.000876	CcSEcCtD
Betahistine—Vomiting—Metformin—type 2 diabetes mellitus	0.000694	0.000874	CcSEcCtD
Betahistine—Rash—Metformin—type 2 diabetes mellitus	0.000689	0.000867	CcSEcCtD
Betahistine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000688	0.000866	CcSEcCtD
Betahistine—Pruritus—Losartan—type 2 diabetes mellitus	0.000686	0.000864	CcSEcCtD
Betahistine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000685	0.000863	CcSEcCtD
Betahistine—Headache—Metformin—type 2 diabetes mellitus	0.000684	0.000861	CcSEcCtD
Betahistine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000682	0.000858	CcSEcCtD
Betahistine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000664	0.000835	CcSEcCtD
Betahistine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000661	0.000832	CcSEcCtD
Betahistine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000655	0.000825	CcSEcCtD
Betahistine—Rash—Irbesartan—type 2 diabetes mellitus	0.00065	0.000818	CcSEcCtD
Betahistine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000649	0.000817	CcSEcCtD
Betahistine—Nausea—Metformin—type 2 diabetes mellitus	0.000649	0.000816	CcSEcCtD
Betahistine—Headache—Irbesartan—type 2 diabetes mellitus	0.000646	0.000813	CcSEcCtD
Betahistine—Dizziness—Losartan—type 2 diabetes mellitus	0.000641	0.000807	CcSEcCtD
Betahistine—Vomiting—Losartan—type 2 diabetes mellitus	0.000617	0.000776	CcSEcCtD
Betahistine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000613	0.000771	CcSEcCtD
Betahistine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000612	0.000771	CcSEcCtD
Betahistine—Rash—Losartan—type 2 diabetes mellitus	0.000612	0.00077	CcSEcCtD
Betahistine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000611	0.000769	CcSEcCtD
Betahistine—Headache—Losartan—type 2 diabetes mellitus	0.000608	0.000765	CcSEcCtD
Betahistine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000597	0.000751	CcSEcCtD
Betahistine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000588	0.000741	CcSEcCtD
Betahistine—Nausea—Losartan—type 2 diabetes mellitus	0.000576	0.000725	CcSEcCtD
Betahistine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000569	0.000716	CcSEcCtD
Betahistine—Dizziness—Ramipril—type 2 diabetes mellitus	0.00055	0.000692	CcSEcCtD
Betahistine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000529	0.000666	CcSEcCtD
Betahistine—Rash—Ramipril—type 2 diabetes mellitus	0.000524	0.00066	CcSEcCtD
Betahistine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000524	0.000659	CcSEcCtD
Betahistine—Headache—Ramipril—type 2 diabetes mellitus	0.000521	0.000656	CcSEcCtD
Betahistine—Nausea—Ramipril—type 2 diabetes mellitus	0.000494	0.000622	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000265	0.00129	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—AKT1—type 2 diabetes mellitus	0.00026	0.00127	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000259	0.00126	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000256	0.00125	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—type 2 diabetes mellitus	0.000255	0.00124	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.000255	0.00124	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.000254	0.00123	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000253	0.00123	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000252	0.00123	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—INSR—type 2 diabetes mellitus	0.00025	0.00122	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.000248	0.00121	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.000247	0.0012	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.000246	0.0012	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.000246	0.0012	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000246	0.0012	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000246	0.0012	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000245	0.00119	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000244	0.00119	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000241	0.00117	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.000241	0.00117	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	0.00024	0.00117	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.000239	0.00116	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	0.000238	0.00116	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.000236	0.00115	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000235	0.00115	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.000235	0.00114	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000234	0.00114	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000232	0.00113	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000232	0.00113	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.000228	0.00111	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000228	0.00111	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000227	0.00111	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000227	0.00111	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000225	0.0011	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000224	0.00109	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000221	0.00108	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.00022	0.00107	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.00022	0.00107	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.000217	0.00106	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000216	0.00105	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000215	0.00105	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000215	0.00105	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000215	0.00104	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000213	0.00104	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	0.00021	0.00102	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000207	0.00101	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000204	0.000992	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.000203	0.000989	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.0002	0.000975	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000199	0.000971	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000199	0.000969	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000197	0.000959	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000197	0.000959	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000196	0.000956	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000194	0.000943	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000193	0.00094	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.000189	0.000921	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	0.000187	0.000913	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000185	0.0009	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000185	0.000898	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000184	0.000897	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000183	0.000892	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000182	0.000888	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000181	0.000881	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000181	0.000881	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000179	0.000874	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000178	0.000868	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000175	0.000852	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000173	0.000845	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000172	0.000838	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000171	0.000834	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.00017	0.000826	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000167	0.000815	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000167	0.000815	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000167	0.000811	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000166	0.000808	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000164	0.0008	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000163	0.000794	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000162	0.000788	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000161	0.000785	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000159	0.000775	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000159	0.000773	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000158	0.00077	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000156	0.000761	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000156	0.000758	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000155	0.000755	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000155	0.000754	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000154	0.000752	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000152	0.000738	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000151	0.000737	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000151	0.000736	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.00015	0.000732	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000146	0.000709	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000146	0.000709	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000145	0.000706	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000144	0.000701	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000144	0.000701	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000142	0.000693	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000141	0.000685	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.00014	0.000681	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—C3—type 2 diabetes mellitus	0.000139	0.000677	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000137	0.000669	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000137	0.000665	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000136	0.000662	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000133	0.000648	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000133	0.000648	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000133	0.000646	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000133	0.000645	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000132	0.000644	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000132	0.000644	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000131	0.000638	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000131	0.000637	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.00013	0.000633	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000129	0.000631	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000129	0.000631	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000128	0.000624	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000128	0.000623	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000127	0.000618	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000124	0.000601	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000122	0.000595	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000122	0.000593	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	0.000122	0.000592	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000121	0.00059	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000121	0.000589	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.00012	0.000586	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000119	0.000581	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000119	0.000579	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000119	0.000578	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000116	0.000567	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000116	0.000562	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000113	0.000551	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—INS—type 2 diabetes mellitus	0.000111	0.000539	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.00011	0.000536	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000109	0.000531	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000109	0.00053	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000108	0.000527	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000107	0.000521	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000107	0.000521	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000106	0.000518	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000105	0.000513	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000104	0.000509	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000103	0.000502	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000102	0.000495	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	9.8e-05	0.000477	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	9.71e-05	0.000473	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.7e-05	0.000472	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.7e-05	0.000472	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	9.63e-05	0.000469	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	9.63e-05	0.000469	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	9.49e-05	0.000462	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	9.38e-05	0.000457	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	9.38e-05	0.000457	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	9.36e-05	0.000456	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	9.36e-05	0.000456	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	9.34e-05	0.000455	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	9.31e-05	0.000453	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	9.23e-05	0.000449	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RELA—type 2 diabetes mellitus	9.13e-05	0.000445	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	8.9e-05	0.000434	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	8.76e-05	0.000427	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	8.57e-05	0.000417	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	8.46e-05	0.000412	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	8.36e-05	0.000407	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.31e-05	0.000405	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	8.31e-05	0.000405	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	8.26e-05	0.000402	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.24e-05	0.000401	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.18e-05	0.000398	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	8.14e-05	0.000396	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	8.11e-05	0.000395	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	8.11e-05	0.000395	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	8.07e-05	0.000393	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	7.96e-05	0.000388	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.78e-05	0.000379	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	7.78e-05	0.000379	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	7.73e-05	0.000376	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.7e-05	0.000375	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.55e-05	0.000368	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	7.52e-05	0.000366	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	7.5e-05	0.000365	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	7.5e-05	0.000365	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	7.39e-05	0.00036	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	7.3e-05	0.000355	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	7.27e-05	0.000354	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	7.26e-05	0.000354	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SRC—type 2 diabetes mellitus	7.18e-05	0.000349	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	7.14e-05	0.000348	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	7.11e-05	0.000346	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	7.11e-05	0.000346	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	7.02e-05	0.000342	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.99e-05	0.00034	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	6.83e-05	0.000333	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	6.62e-05	0.000322	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	6.58e-05	0.000321	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	6.5e-05	0.000317	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	6.5e-05	0.000317	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.41e-05	0.000312	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	6.4e-05	0.000312	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	6.38e-05	0.000311	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.29e-05	0.000306	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.09e-05	0.000296	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.98e-05	0.000291	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.97e-05	0.000291	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	5.66e-05	0.000275	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	5.61e-05	0.000273	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	5.53e-05	0.000269	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.53e-05	0.000269	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.51e-05	0.000268	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.48e-05	0.000267	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.42e-05	0.000264	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	5.34e-05	0.00026	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.32e-05	0.000259	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.26e-05	0.000256	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	5.1e-05	0.000248	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5e-05	0.000243	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.83e-05	0.000235	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.79e-05	0.000233	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.7e-05	0.000229	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	4.59e-05	0.000224	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.46e-05	0.000217	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.38e-05	0.000213	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.37e-05	0.000213	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.37e-05	0.000213	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.29e-05	0.000209	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.28e-05	0.000208	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.28e-05	0.000208	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.23e-05	0.000206	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.03e-05	0.000196	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.82e-05	0.000186	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	3.65e-05	0.000178	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.6e-05	0.000175	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.53e-05	0.000172	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.53e-05	0.000172	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.52e-05	0.000171	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.36e-05	0.000163	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.2e-05	0.000156	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.2e-05	0.000156	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.02e-05	0.000147	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.75e-05	0.000134	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.72e-05	0.000132	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.7e-05	0.000132	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.57e-05	0.000125	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.54e-05	0.000124	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.49e-05	0.000121	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.37e-05	0.000115	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.31e-05	0.000112	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.12e-05	0.000103	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.08e-05	0.000101	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.6e-05	7.78e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.47e-05	7.17e-05	CbGpPWpGaD
